A dose derived linearly from the dose-response relationship at which an additional tumour incidence of 25 % (TD25short forTumor Dose) is to be expected versus the control on the basis of the underlying investigations.
A dose derived linearly from the dose-response relationship at which an additional tumour incidence of 25 % (TD25short forTumor Dose) is to be expected versus the control on the basis of the underlying investigations.